RxDoctor Payments Data

Mary Washington, MD

Anatomic Pathology & Clinical Pathology · Nashville, TNNPI 1629082888

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,058 of the $7,170 with a category attached, or 98.4%. 5 manufacturers reported payments, led by Regeneron at 51.7% of the total. Reporting peaked in 2023 at $6,308 and has fallen 99.3% since, to $47 in 2025. Among anatomic pathology & clinical pathology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,170in general payments, 2019–2025

Across 6 payments — averaging $1194.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$4K
  • GSK$3K
  • Janssen Research & Development, LLC$750
  • Seagen Inc.$65
  • Astellas Pharma US Inc$47
$5,413in research payments, 2019–2025

Across 5 payments — averaging $1082.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • Regeneron$2K

What the payments were for

  • Consulting fees$7,05898%
  • Food & beverage$1122%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,170 in reported general payments places this provider in the 90th percentile of 234 anatomic pathology & clinical pathology providers in Tennessee.

See all anatomic pathology & clinical pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$79,383
Medicare patients
801
Services billed
1,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →